Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy

Clinical trial NCT01100879 · TERMINATED

Trial details

NCT number: NCT01100879
Sponsor: Vifor Pharma
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Iron-Deficiency Anemia

Start date: 2010-03-01
Primary completion: 2011-07-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.